Financial Information

Amyris delivers high-performance alternatives to petroleum, plant and animal-based products across a wide range of consumer and industry segments. Our products offer customers a way to reduce environmental impact with No Compromise® in performance or availability. We are making better chemistry biologically.

The following stock information comes from NASDAQ. Data and charts may be delayed by 15 minutes or more.

 

 

NASDAQAMRS
Beta0.51
Shares Outstanding163.1M
Average Volume (10 days)4.6M
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($2.49)
Sales (TTM)$1.03
Book Value (MRQ)($1.08)
Cash Flow (TTM)($1.38)
Cash (MRQ)$2,607,000.00

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy2
 
Buy0
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Nicole Kelsey
General Counsel and Secretary
(11,433)
Dispose
May 1, 2020
John Melo
Director, President and CEO
(5,378)
Dispose
May 1, 2020
John Melo
Director, President and CEO
(6,676)
Dispose
May 1, 2020
Hermanus Kieftenbeld
Chief Financial Officer
67,500
Acquire
Mar 30, 2020
John Melo
Director, President and CEO
(52,785)
Sell
Feb 19, 2020

Recent SEC Filings

EFFECT
May 29, 2020
DEFA14A
May 15, 2020
S-1
May 12, 2020
Quarterly Financials
May 11, 2020
Amended >= 5% Acquisition
May 11, 2020